B-cell Acute Lymphoblastic Leukemia Clinical Trials in Cincinnati, Ohio

4 studies are recruiting for b-cell acute lymphoblastic leukemia in Cincinnati, Ohio right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

    The researchers are doing this study to find out whether PK-targeted fludarabine is an effective Lymphodepletion (LD) chemotherapy approach for people with relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL) who will receive tisagenlecleucel CAR T-cell therapy. The researchers will comp…

    Stage
    Phase 3
    Ages
    1 and older
    Site
    Cincinnati Children's Hospital Medical Center (Data Collection Only), Cincinnati, Ohio
    Locations
    6 in total
    Run by
    Memorial Sloan Kettering Cancer Center

    See if you can join NCT07223021 on ClinicalTrials.gov

  2. Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

    This study is for older children, adolescents, and young adults with B-cell Acute Lymphoblastic Leukemia (B-ALL). Higher amounts of body fat is associated with resistance to chemotherapy in patients with B-ALL. Chemotherapy during the first month causes large gains in body fat in most people, even …

    Stage
    Phase 2
    Ages
    7 to 25
    Site
    Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
    Locations
    16 in total
    Run by
    Etan Orgel

    See if you can join NCT05082519 on ClinicalTrials.gov

  3. Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALL

    The goal of this clinical trial is to learn if the combination of drugs Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone (IoVeX) are safe to treat relapsed B-cell Acute Lymphoblastic Leukemia (B-ALL) in pediatric and adult patients. It will also learn if these drugs are well tolerated. The main…

    Stage
    Phase 1
    Ages
    1 to 39
    Site
    Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
    Run by
    Children's Hospital Medical Center, Cincinnati

    See if you can join NCT06863259 on ClinicalTrials.gov

  4. Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

    Dose Escalation - Determine the maximum tolerated dose (MTD), if possible, or minimum optimal biologic dose (OBD), and evaluate the safety and tolerability of VIP943 in subjects with advanced CD123+ hematologic malignancies

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of Cincinnati, Cincinnati, Ohio
    Locations
    5 in total
    Run by
    Vincerx Pharma, Inc.

    See if you can join NCT06034275 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.